For the experienced in IPR

 

US9677038 Cercore 2 Page 1US10288060 Cerphragm 1 Page 1US11414642B2 Cellmembra Stobbe Page 1US20230042475A1 Cellmembra 2Nd Page 1Cellretention 2023 0056468 Page 01Cellretention ForsideCerphragm 2 US10508647US9228579 Cercore1 Page 1

Please find here some of the patents and applications and owned by Stobbe Group illustrated - all within the pharma world.

------------------------------------

CerCore1 - "Method and device for industrial biolayer cultivation" - packed-bed bioreactor for expression or proliferation 

  • EP patent granted - EP2379699
  • Germany patent granted - EP2379699
  • Switzerland patent granted – EP2379699
  • England patent granted - EP2379699
  • France patent granted - EP2379699

CerCore1 - "Method and device for industrial biolayer cultivation"

  • US patent granted - US 9,228,579

CerCore2 - "Device and method for industrial cultivation of cells" 

  • US patent granted - US 9,677,038

 ----------------------------- 

CerPhragm 1 - "Electronically controlled diaphragm pump" 

  • EP patent granted - EP2379889
  • Germany patent granted – 60 2009 033 969.9
  • Switzerland patent granted – EP2379889
  • England patent granted – EP2379889
  • France patent granted – EP2379889
  • Italy patent granted - EP2379889

CerPhragm 2 - "Electronically controlled diaphragm pump" (including fluid valves)

  • US patent granted - US 10,288,060

CerPhragm 3 - "Electronically controlled diaphragm pump" (excluding fluid valves)

  • US patent granted – US 10,508,647

 -------------------------------  

CellMembra - "Disposable Bioprocess System supporting biological activity" (including fluid valves)

  • EP pending - 16724365.8 
  • Canada pending - 2,993,709
  • US patent granted #1 - US 11,414,642
  • US patent granted #2 - US 12,110,484
  • China pending - 2016800571984 
  • South Korea granted - 10-2621101
  • South Korea pending - 10-2023-7037669
  • Japan patent granted #1- 7298054
  • Japan divisional / continuation #2 - 2023-078318

 US continuations

  • US patent application-3 – US 2023/0042475

 ---------------------------------

CellRetention - "Disposable Bioprocess System for biological activity" (excluding fluid valves)

  • US patent granted #1 - US 12,157,878

 US continuations

  • US patent application #2 - US 2023/0056468
  • US patent application #3 - US 2023/0203426

------------------------------------

SilCon - "Simplified fluid connection and membrane filter" - Hollow-Fibre-Filter cartridge and simplified connections

  • PCT application published 2021-04-14 - WO2021069586
  • US patent application - US 2022/0347630A1
  • EP patent application - 20789080.7

------------------------------------- 

Rotating SUB – “Bioprocess System extending a biological process“ - continues processing

  • PCT application - PCT/EP2024/066212 - 2024-06-12

-----------------------------------

Rotating valve – "A No-Dead-Volume-Valve for fluid control" - not published yet

  • DK application - DK/PA 2024/30452 - 2024-08-07

------------------------------------- 

updated 2024-11-20